Repertoire Genesis
Osaka
About Repertoire Genesis
Repertoire Genesis supports the realization of new diagnostic methods / therapeutic methods related to personalized medicine by utilizing T cell / B cell receptor retort analysis and neo-epithelial analysis.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.6M
- Funding stage: M&A
- Last round: Corporate Round (Sep 2019)
- Website: repertoire.co.jp
Industries & Categories
Biotechnology, Product Research, Renewable Energy
Social Profiles
Canonical: https://fsome.com/organization/repertoire-genesis-32963 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.